| 1 |
32729019 | Marketing of Tenofovir Disoproxil Fumarate (TDF) Lawsuits and Social Media Misinformation Campaigns' Impact on PrEP Uptake Among Gender and Sexual Minority Individuals. | 2021 May |
3 |
| 2 |
32766890 | Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study. | 2021 Oct 5 |
1 |
| 3 |
33507010 | Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP. | 2021 Mar 1 |
1 |
| 4 |
29971734 | Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China. | 2019 Feb |
1 |
| 5 |
31430318 | Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study. | 2019 |
1 |
| 6 |
26364263 | Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. | 2016 Jan 2 |
2 |
| 7 |
26781865 | Does Adherence Change When No One is Looking? Comparing Announced and Unannounced Tenofovir Levels in a PrEP Trial. | 2016 Nov |
2 |
| 8 |
27846073 | Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence. | 2016 Dec 15 |
1 |
| 9 |
26559816 | Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort. | 2015 |
1 |
| 10 |
26204593 | Tenofovir/FTC approved for PrEP...but issues remain regarding implementation. | 2012 Sep |
1 |